Angiochem's ANG1005 Shows Clinical Benefits and Prolonged Survival for Breast Cancer Patients With Brain Metastases
17 oct. 2016 07h00 HE
|
Angiochem
MONTREAL, QC--(Marketwired - October 17, 2016) - Angiochem, a biotechnology company developing peptide-drug conjugates uniquely capable of crossing the blood-brain barrier, recently presented data...
Angiochem to Present at ESMO 2016 Congress
03 oct. 2016 07h00 HE
|
Angiochem
MONTREAL, QC--(Marketwired - October 03, 2016) - Angiochem, a biotechnology company developing peptide drug conjugates uniquely capable of crossing the blood-brain barrier, announced it will make a...
National Brain Tumor Society & Memorial Sloan Kettering Agreement Bolsters Research Efforts to Combat Deadliest Brain Cancer
06 juil. 2016 15h36 HE
|
National Brain Tumor Society
BOSTON, MA--(Marketwired - July 06, 2016) - National Brain Tumor Society (NBTS), the largest nonprofit organization in the U.S. dedicated to the brain tumor community, today announced that it has...
PharmaCyte Biotech's Dr. Mark Rabe Discusses the Significance of Schedule 1 License to Company's Future in Cannabis Research
18 juin 2015 09h00 HE
|
PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - June 18, 2015) - PharmaCyte Biotech (OTCQB: PMCB) announced this week that the Company is able to advance its Cannabis research now that its research partner, The...
Mazor Robotics Announces Major Milestone in Improving the Management of Lethal Brain Cancer in Children
03 févr. 2015 08h10 HE
|
Mazor Robotics
ORLANDO, FLA., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Mazor Robotics (www.mazorrobotics.com), a global leader in the development and distribution of innovative surgical guidance systems for spine and brain...
ISR's Brain Cancer (Glioblastoma Multiforme) Report Analyzes Market Opportunity, Product Pipelines
19 févr. 2014 09h59 HE
|
Industry Standard Research
CARY, NC--(Marketwired - Feb 19, 2014) - Industry Standard Research (ISR) today announced the release of a new market research report titled "Brain Cancer (Glioblastoma Multiforme): Disease and...
Nuvilex's Dr. Mark Rabe Talks Medical Marijuana, Legalization and Cell-in-a-Box
12 févr. 2014 09h00 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Feb 12, 2014) - Nuvilex, Inc. (OTCQB: NVLX) is a biotechnology company that's focused on getting into late phase clinical trials for the treatment of advanced,...
Nuvilex Expects to Continue Success of Cell-in-a-Box Technology with Marijuana-Based Treatments
10 févr. 2014 09h00 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Feb 10, 2014) - If Nuvilex, Inc. (OTCQB: NVLX) can use the Cell-in-a-Box™ technology to develop marijuana-based treatments for cancer with the same success it has...
Nuvilex, Inc.'s Marijuana Research and Treatments Get Closer With Banking Discussions
27 janv. 2014 09h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 27, 2014) - Nuvilex, Inc. (OTCQB: NVLX) has emerged as a biotechnology firm that will develop treatments for both Cancer and Diabetes using the Cell-in-a-Box™...
Obama's Shifting Opinion Good News for Marijuana Industry and Nuvilex
21 janv. 2014 09h30 HE
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 21, 2014) - Nuvilex, Inc. (OTCQB: NVLX) executives had to perk up when they heard the news coming from The New Yorker magazine's interview with President Obama...